Skip to content

SION SION Preferred Stock

Preferred Stock at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$0
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$0

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is SION's preferred stock?
SION (SION) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.